Related Experiment Video
Updated: May 4, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Conversations in cardiology: bridging antiplatelet therapy before surgery
Morton J Kern1, Robert J Applegate, Malcolm Bell
1University California Irvine, Chief Cardiology, Long Beach Veterans Administration Heath Care System, Long Beach, California; University of California, Irvine Medical Center, Orange, California.
Abstract:
Bridging for antiplatelet therapy remains a subject of debate with data favoring GP blockers but at a risk of bleeding. This Conversation in Cardiology addresses a key and often asked question about use of alternatives to P2Y12 agents in patients requiring surgery within 6 months after drug eluting stent implantation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Atherosclerosis III: Management

